Previous 10 | Next 10 |
2023-12-29 16:36:51 ET More on Cano Health UBS cuts Cano Health to sell, cites deteriorating liquidity position Cano Health GAAP EPS of -$91.87 misses by $75.32, revenue of $788.1M beats by $21.73M Seeking Alpha’s Quant Rating on Cano Health For furthe...
Cano Health Receives NYSE Notice of Non-Compliance with Market Capitalization Criteria PR Newswire Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions MIAMI , Dec. 29, 2023 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) (" ...
2023-12-21 12:18:35 ET Gainers: Infrared Cameras Holdings ( MSAI ) +195% . Mullen Automotive ( MULN ) +112% . Baijiayun Group Ltd ( RTC ) +33% . HeartBeam ( BEAT ) +31% . Triumph Group ( TGI ) +32% . TC BioPharm ( TCBP ) ...
2023-12-21 10:00:01 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector For further details see: Cassava Sciences, Myomo among healthcare movers
Cano Health Announces Appointment of Two New Independent Directors PR Newswire Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives MIAMI , Dec. 18, 2023 /PRNewswire/ --...
2023-12-08 12:45:17 ET Gainers: Intensity Therapeutics ( INTS ) +100% . MBIA ( MBI ) +74% . Conduit Pharmaceuticals ( CDT ) +47% . EF Hutton Acquisition Corp I ( EFHT ) +44% . Alx Oncology Holdings ( ALXO ) +35% . View ( VI...
2023-11-17 10:28:33 ET More on Cano Health Cano Health, Inc. 2023 Q3 - Results - Earnings Call Presentation Cano Health, Inc. (CANO) Q3 2023 Earnings Call Transcript Cano Health GAAP EPS of -$91.87 misses by $75.32, revenue of $788.1M beats by $21.73M Cano He...
2023-11-10 11:45:20 ET Cano Health (NYSE: CANO) stock price has crashed as concerns about the company’s future remained. The shares tumbled by more than 19% on Friday and reached an all-time low of $6.62. They have lost almost 100% of their value from their all-time high. Ban...
2023-11-09 20:54:07 ET Cano Health, Inc. (CANO) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Mark Kent – Chief Executive Officer Eladio Gil – Interim Chief Financial Officer Conference Call Participants E...
Cano Health Provides Update on Third Quarter 2023 10-Q Filing PR Newswire MIAMI , Nov. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, provided the...
News, Short Squeeze, Breakout and More Instantly...
Cano Health Inc. Class A Company Name:
CANO Stock Symbol:
NYSE Market:
NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings PR Newswire MIAMI , Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024 , the New York Stoc...
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomi...
On Monday, value-based primary care provider Cano Health Inc (NASDAQ:CANO) entered into a Restructuring Support Agreement with lenders ho...